Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Aisha Walker, PhD
Researcher Assistant Professor of Medicine
Division of Pulmonary,
Allergy and Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh
E1226-0A BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Walker is a Research Assistant Professor in the Vascular Medicine Institute at University of Pittsburgh. Dr. Walker is currently a Sickle Cell Scholar at Pitt. Her basic and translational research projects continue to investigate mechanisms related to pharmacologic therapies for sickle cell disease.
Dr. Walker’s primary research goal is to identify novel therapeutic strategies for the treatment of sickle cell disease (SCD). Her current projects are focused on identifying cellular and molecular modulators that mediate efficacy and toxicity of hydroxyurea, which is currently the only FDA approved drug for SCD. Dr. Walker’s work was the first to identify specific cell membrane transporters and microRNAs associated with the pharmacokinetics and clinical outcomes of hydroxyurea.
+myBinderRelated Content
-
Jeffrey Andolina, MD, MSDr. Andolina is the director of pediatri...
-
The effects of relaxation intervention on pain, stress, and autonomic responses among adults with sickle cell pain i...Pain is the major complication for the a...
-
Sickle Cell Disease – Hydroxyurea: What You Need to KnowIf you have sickle cell disease, your bo...
-
Randomized Trials Needed to Assess Benefits of Salmonella Vaccines in SCD Patients, Study SaysRandomized controlled trials are needed ...
-
CRISPR deployed to combat sickle-cell anaemiaA mutation in a single DNA letter causes...
-
Sickle-Cell Patients See Hope in CRISPRSickle-cell disease is one of the most c...
-
L-glutamine Oral Powder Significantly Reduces Acute Complications of Sickle Cell DiseaseApproved by the US Food and Drug...
